Brimonidine Tartrate

CAS 70359-46-5 12 current records 1 historicalSmall Molecule

Who holds supplier records for Brimonidine Tartrate? 12 organisations hold a current record for Brimonidine Tartrate: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 11 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), Spain (1) and United States (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Brimonidine Tartrate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/brimonidine-tartrate

Reading the evidence

  • 12 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    8 of the 10 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (12)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Brimonidine Tartrate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India8Spain1United States1Country not recorded for 2
  • CENTAUR PHARMACEUTICALS PVT LTD
    Active DMF 23880 · latest filing Jun 2010
    IndiaCEP Company GMP cert on record
  • CZECH-GEN AS
    Active DMF 15585 · latest filing Aug 2001
    CEP Company GMP cert on record
  • INDOCO REMEDIES LTD
    Active DMF 22166 · latest filing Oct 2008
    IndiaCEP Company GMP cert on record
  • MAITHRI DRUGS PRIVATE LTD
    Active DMF 36595 · latest filing Dec 2021
    IndiaCEP Company GMP cert on record
  • MEDICHEM SA
    Active DMF 15601 · latest filing Aug 2001
    SpainCEP Company GMP cert on record
  • MICRO LABS LTD
    Active DMF 34362 · latest filing Dec 2019
    IndiaCEP Company GMP cert on record
  • Piramal Pharma Limited
    Active DMF 17588 · latest filing Aug 2004
    IndiaCEP Company GMP cert on record
  • SIEGFRIED GRAFTON INC
    Active DMF 24213 · latest filing Sept 2010
    CEP
  • Viyash Scientific Ltd
    Active DMF 22230 · latest filing Dec 2008
    IndiaCEP Company GMP cert on record
  • C-SQUARED PHARMA LTD
    Active DMF 22510 · latest filing Jan 2009
    United StatesCEP
  • FDC Limited
    Active DMF 20855 · latest filing Sept 2007
    IndiaCEP Company GMP cert on record
  • Unichem Laboratories Ltd.
    Active DMF 25051 · latest filing Jul 2011
    India Company GMP cert on record
Need Brimonidine Tartrate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (11)

Certificates of Suitability on the EDQM register for Brimonidine Tartrate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
CZECH-GEN A.S. OlomoucCZ
CEP 2014-331 - Rev 05
Brimonidine tartrate
Jul 2026Inspected Sept 2024
Czechia
VIYASH SCIENTIFIC LIMITED HyderabadIN
CEP 2018-124 - Rev 03
Brimonidine tartrate
Jul 2026—
FDC LIMITED MumbaiIN
CEP 2020-123 - Rev 02
Brimonidine tartrate
May 2026—
SIEGFRIED GRAFTON, INC. GraftonUS
CEP 2015-265 - Rev 01
Brimonidine tartrate
Aug 2025—
MICRO LABS LIMITED BengaluruIN
CEP 2019-335 - Rev 03
Brimonidine tartrate
Jun 2025—
CENTAUR PHARMACEUTICALS PRIVATE LIMITED MumbaiIN
CEP 2022-451 - Rev 00
Brimonidine tartrate
Nov 2024—
INDOCO REMEDIES LIMITED MumbaiIN
CEP 2014-180 - Rev 01
Brimonidine tartrate
Mar 2024—
C-SQUARED PHARMA LIMITED CorkIE
CEP 2022-161 - Rev 00
Brimonidine tartrate
Feb 2024—
MAITHRI DRUGS PRIVATE LIMITED Bonthapally VillageIN
R0-CEP 2021-507 - Rev 00
Brimonidine tartrate
Jul 2023—
PIRAMAL PHARMA LIMITED Digwal VillageIN
R1-CEP 2015-052 - Rev 01
Brimonidine tartrate
Jan 2022—
Medichem, S.A. Sant Joan DespíES
R1-CEP 2013-353 - Rev 00
Brimonidine tartrate
Apr 2019—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Brimonidine Tartrate are no longer active. These show a past filing, not current supply.

Show all 1 historical record

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Brimonidine Tartrate is an alpha-2 adrenergic receptor agonist primarily used to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It works by decreasing the production of aqueous humor and increasing uveoscleral outflow.

Chemical identity

IUPAC name
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine;(2R,3R)-2,3-dihydroxybutanedioic acid
Canonical SMILES
C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
InChIKey
QZHBYNSSDLTCRG-LREBCSMRSA-N
Synonyms
Mirvaso API, agn 190342-lf, agn-190342-lf, agn-190342lf, alphagan, brimonidine d-tartrate, bromoxidine tartrate, cd-07805, cd-07805/47, cd07805/47, combigan component brimonidine tartrate, lumify

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
alpha-Adrenergic Agonist
Mechanism of action
Adrenergic alpha-Agonists

Therapeutic areas

OphthalmologyGlaucoma TreatmentOptic Pressure Management

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Brimonidine Tartrate?

12 organisations hold an active US FDA Type II Drug Master File or a CEP for Brimonidine Tartrate: CENTAUR PHARMACEUTICALS PVT LTD (India), CZECH-GEN AS, INDOCO REMEDIES LTD (India), MAITHRI DRUGS PRIVATE LTD (India), MEDICHEM SA (Spain), MICRO LABS LTD (India), Piramal Pharma Limited (India) and SIEGFRIED GRAFTON INC, and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Brimonidine Tartrate Drug Master Files are active?

CENTAUR PHARMACEUTICALS PVT LTD (DMF 23880), CZECH-GEN AS (DMF 15585), INDOCO REMEDIES LTD (DMF 22166), MAITHRI DRUGS PRIVATE LTD (DMF 36595), MEDICHEM SA (DMF 15601), MICRO LABS LTD (DMF 34362), Piramal Pharma Limited (DMF 17588) and SIEGFRIED GRAFTON INC (DMF 24213) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Brimonidine Tartrate records mean?

1 organisation has only inactive Type II DMFs for Brimonidine Tartrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Brimonidine Tartrate have a European Certificate of Suitability?

Yes. 11 organisations hold a valid CEP for Brimonidine Tartrate on the EDQM register, including CZECH-GEN A.S. Olomouc (CZ), VIYASH SCIENTIFIC LIMITED Hyderabad (IN), FDC LIMITED Mumbai (IN), SIEGFRIED GRAFTON, INC. Grafton (US), MICRO LABS LIMITED Bengaluru (IN) and CENTAUR PHARMACEUTICALS PRIVATE LIMITED Mumbai (IN) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Brimonidine Tartrate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Brimonidine Tartrate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.